Status:
COMPLETED
Long-term Effects of Interventional Strategies to Prevent Cognitive Decline in Elderly.
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Frail Elderly
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The MAPT PLUS study is a two-year extension of follow-up of the patients included in the MAPT preventive study, after completion of the interventions. Subjects in the four groups of the MAPT study wil...
Detailed Description
The MAPT PLUS study is a follow-up of subjects initially included in an interventional study. The follow-up that we propose in this request for funding does not involve any intervention, but aims to a...
Eligibility Criteria
Inclusion
- Subjects who meet the following criteria will be included in the MAPT PLUS study :
- frail elderly subjects participating in the MAPT study and still followed at 3 years,
- subjects capable of understanding the protocol, complying with its requirements and attending the follow-up visits proposed as part of the extended phase of the MAPT study,
- subjects capable of giving their written informed consent and complying with the requirements of the study,
- subjects covered by a health insurance system.
Exclusion
- Subjects who fulfill at least one of the following criteria will not be included in the MAPT PLUS study :
- known presence of dementia or Alzheimer's disease (DSM IV criteria) diagnosed during the MAPT follow-up,
- known presence of severe diseases that are life-threatening in the short term,
- visual or hearing impairments that are incompatible with performance and/or interpretation of the neuropsychological tests,
- history and/or presence of any disorder (severe depression or generalized anxiety) which, according to the investigator, is likely to interfere with the results of the study or to expose the subject to a supplementary risk,
- participation in another clinical study during the period of the present study,
- subjects who have refused cognitive evaluation during the MAPT follow-up,
- subjects deprived of their freedom by administrative or judicial decision, or under guardianship,
- with regard to performance of MRI: presence of a pacemaker or metallic materials, claustrophobia.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2020
Estimated Enrollment :
1028 Patients enrolled
Trial Details
Trial ID
NCT01513252
Start Date
December 1 2011
End Date
July 20 2020
Last Update
June 3 2024
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux
Bordeaux, France
2
CH Castres-Mazamet
Castres, France
3
CHRU Dijon
Dijon, France
4
CHIVA
Foix, France